Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

Farzana D Pashankar A Lindsay FrazierMark KrailoCaihong XiaAlberto S PappoMarcio MalogolowkinThomas A OlsonCarlos Rodriguez Galindo

Published in: Pediatric blood & cancer (2018)

TIC is active in relapsed pediatric MGCT and should be considered for salvage therapy in children. In adolescents and older adults with relapse MGCT, TIP or high-dose chemotherapy with stem cell remain the standard therapy.

Keyphrases

young adults
stem cells
high dose
germ cell
physical activity
acute lymphoblastic leukemia
palliative care
acute myeloid leukemia
clinical trial
radiation therapy
mesenchymal stem cells
multiple myeloma
hodgkin lymphoma
cell therapy
phase ii study
phase iii